In addition, we found evidence of biallelic inactivation (loss of heterozygosity and a loss-of-function mutation) for multiple tumor suppressors (PTEN, TP53, NF1) in the tumor but not in ctDNA samples, in which we could only identify the loss-of-function mutations. The gene discussed is PTEN; the disease is neoplasm.